Pathophysiology of Hemolytic Transfusion Reactions

https://doi.org/10.1053/j.seminhematol.2005.04.006Get rights and content

Hemolytic transfusion reactions (HTR) are systemic reactions provoked by immunologic red blood cell (RBC) incompatibility. Clinical and experimental observations of such reactions indicate that they proceed through phases of humoral immune reaction, activation of phagocytes, productions of cytokine mediators, and wide-ranging cellular responses. HTR have many features in common with the systemic inflammatory response syndrome (SIRS). Knowledge of the pathophysiologic mechanisms in HTR suggest that newer biological agents that target complement intermediates or proinflammatory cytokines may be effective agents in the treatment of severe HTRs.

References (19)

  • R.D. Davenport et al.

    Interleukin-8 production in red blood cell incompatibility

    Blood

    (1990)
  • M.D. Coopamah et al.

    Anti-D initially stimulates and Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist

    Blood

    (2003)
  • S.J. Ruegg et al.

    Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells

    Immunology

    (1988)
  • R.G.Q. Leslie

    Immunoglobulin and soluble immune complex binding to phagocyte Fc receptors

    Biochem Soc Trans

    (1984)
  • R.D. Davenport et al.

    IgG receptor roles in red cell binding to monocytes and macrophages

    Transfusion

    (1994)
  • J.C. Unkeless

    Function and heterogeneity of human Fc receptors for immunoglobulin G

    J Clin Invest

    (1989)
  • S.B. Clarkson et al.

    Blockade of clearance of immune complexes by anti-Fc gamma receptor monoclonal antibody

    J Exp Med

    (1986)
  • J. Butler et al.

    Systemic release of neutrophil elastase and tumour necrosis factor alpha following ABO incompatible blood transfusion

    Br J Haematol

    (1991)
  • R.D. Davenport et al.

    Red Cell ABO Incompatibility and production of tumour necrosis factor-alpha

    Br J Haematol

    (1991)
There are more references available in the full text version of this article.

Cited by (56)

  • Cognition and translational research

    2022, Perioperative Neuroscience: Translational Research
  • Postpartum hemorrhage: Blood product management and massive transfusion

    2019, Seminars in Perinatology
    Citation Excerpt :

    In cases of multiple antibodies, unexpected incompatibility can occur and result in acute hemolytic reactions. Acute hemolytic reactions usually occur during or within 24 h of blood transfusion and clinically present with fever, chills, hypotension, hemoglobinuria, renal failure, back pain, and signs of DIC.28 In the most severe form the recipient can have hyper-hemolysis syndrome where both donor and recipient blood cells are destroyed.

  • Update on extracellular vesicles inside red blood cell storage units: Adjust the sails closer to the new wind

    2016, Transfusion and Apheresis Science
    Citation Excerpt :

    The characteristic composition of RBC-derived EVs in numerous complement components and IgGs suggests a strong proinflammatory potential and transfusion-related immune modulation [40,46,95]. The complement system is the underlying cause of many adverse effects of blood transfusion including hemolytic reaction [96], anaphylactic reaction [97], and transfusion related acute lung injury (TRALI). The RBC EVs-bound IgG and complement components can activate neutrophils via Fc receptors, as a piece of the pathogenesis of TRALI [98].

View all citing articles on Scopus
View full text